{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:21:45Z","timestamp":1778862105128,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jaci.2019.08.014","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:17:50Z","timestamp":1566904670000},"page":"1731-1734.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["IL-12\/IL-23 neutralization is ineffective for alopecia areata in mice and humans"],"prefix":"10.1016","volume":"144","author":[{"given":"Luana S.","family":"Ortolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa Rang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Crotts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany G.","family":"Craiglow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Wambier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato S.","family":"Paschoal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.08.014_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.08.014_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ebiom.2016.03.036","article-title":"Molecular signatures define alopecia areata subtypes and transcriptional biomarkers","volume":"7","author":"Jabbari","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaci.2019.08.014_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.08.014_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.08.014_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.08.014_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation\u00a0without parallel TH17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.014_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.014_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jdcr.2017.07.009","article-title":"Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata","volume":"3","author":"Elkady","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2019.08.014_bibE1","first-page":"e44","article-title":"Response to ustekinumab in three pediatric patients with alopecia areata","volume":"36","author":"Lim","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE2","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of alopecia areata to C3H\/HeJ mice using cultured lymph node-derived cells","volume":"135","author":"Wang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1523-1747.1998.00380.x","article-title":"Experimental induction of alopecia areata-like hair loss in C3H\/HeJ mice using full-thickness skin grafts","volume":"111","author":"McElwee","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE5","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/1521-4141(200107)31:7<2227::AID-IMMU2227>3.0.CO;2-C","article-title":"Early Th1\/Th2 cell polarization in the absence of IL-4 and IL-12: T cell receptor signaling regulates the response to cytokines in CD4 and CD8 T cells","volume":"31","author":"Noble","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20062305","article-title":"CD8\u2212 DCs induce IL-12\u2013independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS","volume":"204","author":"Skokos","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.08.014_bibE7","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/eji.200526258","article-title":"IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus","volume":"35","author":"Yu","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1684\/ejd.2013.2221","article-title":"Alopecia areata developing during ustekinumab therapy: report of two cases","volume":"23","author":"Tauber","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D34G31C0TM","article-title":"Letter: Alopecia areata during ustekinumab administration: co-existence or an adverse reaction?","volume":"18","author":"Verros","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaci.2019.08.014_bibE10","first-page":"1","article-title":"Induction of alopecia areata in C3H\/HeJ mice via cultured cell transfer","author":"Wang","year":"2014","journal-title":"Nat Protoc Exch"},{"key":"10.1016\/j.jaci.2019.08.014_bibE11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/exd.12709","article-title":"CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin","volume":"24","author":"Brunner","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.014_bibE12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/IAI.01100-15","article-title":"Lymphoid and nonlymphoid compartments are controlled systemically by interleukin-27 and ICOS during blood-stage malaria infection","volume":"84","author":"Villegas-mendez","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2019.08.014_bibE13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.25982","article-title":"High-mobility group box 1 (HMGB1)-toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of \u03b3\u03b4 T cells with macrophages","volume":"57","author":"Wang","year":"2013","journal-title":"Hepatology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919311005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919311005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:22:41Z","timestamp":1758792161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919311005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0091674919311005"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.08.014","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-12\/IL-23 neutralization is ineffective for alopecia areata in mice and humans","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}